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Figure S2. Labeling of the catalytic domains of SENP1 and SENP6 enzymes with
Rho-SUMOG-PA probes. M = marker, S1 = Rho-SUMO-1-PA, S2 = Rho-SUMO-2-
PA, S3 = Rho- . 
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Figure S3. Activity-based profiling with SUMO ABPs. Labeling of ectopically expressed FLAG-SENPs 1-7 and FLAG-USP15 (negative control) in HeLa cell
Figure S5. Analysis of K11 diSUMO-2-VA A) by SDS-PAGE and B) CD Spectrum.
S6 Figure S6 . Labeling of the catalytic domains of SENP1, 2, 5, 6, 7 and 8 with K11 diSUMO-2-VA. Asterisks (*) indicate probe-labeled SENP.
Figure S7. Time-dependent labeling of endogenous SENP1, SENP3 and SENP6 with A) SUMO-1-PA; B) SUMO-2-PA and C) diSUMO-2-VA. In contrast to the SUMO-
1-PA and SUMO-2-PA probes, all of the tested SENPs readily react with the diSUMO-2-VA as depicted in C). Unlike SENP1, SENP3 appears to prefer diSUMO2-
VA to 
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General procedures
Fmoc SPPS strategy SPPS was performed on a Syro II MultiSyntech Automated Peptide synthesizer using standard 9-fluorenylmethoxycarbonyl (Fmoc) based solid phase peptide chemistry at 40 μmol scale using fourfold excess of amino acids relative to pre-loaded Fmoc amino acid trityl resin (0.2 mmol/g, Applied Biosystems®). All amino acids and dipeptide building blocks were double coupled in NMP for 45 min using PyBOP (4 equiv) and DiPEA (8 equiv) as coupling regents. The following protected pseudoproline and DMB dipeptide building blocks were used during the SUMO synthesis as indicated in Figure 1 : Figure S11 ).
Cleavage from the resin and deprotection
The polypeptide sequence was detached from the resin and deprotected by 
Dissolving and folding of synthetic SUMO conjugates.
The SUMO protein is dissolved in a minimal amount of warm DMSO at a concentration of 40-60 mg/ml. Then refolding was done by dropwise addition of the DMSO stock to water or buffer of choice. The final DMSO concentration is kept as low as possible (2 -5%).
CD measurements
The structural conformation of our synthetic SUMO constructs were validated using circular dichroism (CD). The samples were dissolved in DMSO at a concentration of 50 mg/ml. Refolding was done by dissolving 10 µl of this DMSO stock in 2.5 ml MQ water. After a brief vortex, 2.5 ml of 20 mM sodium phosphate buffer (pH 7.0) was added to this solution. To remove DMSO from the sample, we used 3 kDa cut-off Amicon Ultra-15 Centrifugal Filter Units and exchanged the solvent for 20 mM sodium phosphate buffer (pH 7.0). Complete removal of DMSO was followed by the disappearance of DMSO peak in LC/MS. Final concentrations of the SUMO conjugates were measured using standard BCA assay. The CD measurements were made using JASCO CD J1000 series instrument at 25 ˚C. Samples were diluted in 20 mM sodium phosphate buffer (pH 7.0) so that the final concentration was approximately 10 µM. The CD spectra was recorded from 250 nm to 190 nm at a scan rate of 20 nm per minute and a scan width of 1 nm. A quartz cuvette with a path length of 1 mm was used in all measurements. In total, 8 cumulative measurements were made and the average was calculated and plotted using Graphpad PRISM.
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Synthesis of SUMO
SUMO-1
The synthesis was performed following the general procedure. The crude product was purified by preparative HPLC as described in the general procedure. LC-MS: Rt 4.30 min; ESI MS+ (amu) calcd: 11130, found 11130 (deconv.).
SUMO-2
The synthesis was performed following the general procedure. The crude product was purified by preparative HPLC as described in the general procedure. LC-MS: Rt 4.23 min; ESI MS+ (amu) calcd: 10607, found 10607 (deconv.).
SUMO-3
The synthesis was performed following the general procedure. The crude product was purified by preparative HPLC as described in the general procedure. LC-MS: Rt 4.20 min; ESI MS+ (amu) calcd: 10523, found 10523 (deconv.).
SUMO-1G
The synthesis was performed following the general procedure. The methionine and cysteine residues in the sequence were replaced by the known isosters norleucine and serine, respectively that do not interfere with normal function of the protein. After completing all coupling cycles, 687 mg resin was obtained. For analysis, 154 mg of this resin was weighed and used for detachment and deprotection of the polypeptide product. The crude product was purified by preparative HPLC as described in the general procedure. The final product was lyophilized and obtained as a white solid (6 mg, 10%); LC-MS: R t 6.34 min; ESI MS+ (amu) calcd: 10986, found 10988 (deconv.).
SUMO-2G
The synthesis was performed following the general procedure. The methionine and cysteine residues in the sequence were replaced by the known isosters norleucine and serine, respectively that do not interfere with normal function of the protein. After completing all coupling cycles, 792 mg resin was obtained. For analysis, 154 mg of this resin was weighed and used for detachment and deprotection of the polypeptide product. The crude product was purified by preparative HPLC as described in the S13 general procedure. The final product was lyophilized and obtained as a white solid (17 mg, 21%); LC-MS: R t 4.38 min; ESI MS+ (amu) calcd: 10462, found 10462 (deconv.).
SUMO-3G
The synthesis was performed following the general procedure. The methionine and cysteine residues in the sequence were replaced by the known isosters norleucine and serine, respectively that do not interfere with normal function of the protein. After completing all coupling cycles, 704 mg resin was obtained. For analysis, 153 mg of this resin was weighed and used for detachment and deprotection of the polypeptide product. The crude product was purified by preparative HPLC as described in the general procedure. The final product was lyophilized and obtained as a white solid (27 mg, 30%); LC-MS: R t 4.32 min; ESI MS+ (amu) calcd: 10379, found 10378 (deconv.).
Preparation of SUMO probes
Rho-SUMOG-PA probes
The SUMOG peptide sequence was synthesized on a trityl resin following the general procedure. The methionine and cysteine residues in the sequence were replaced by the known isosters norleucine and serine, respectively that do not 
Rho-SUMO-1G-PA
The product (24 mg, 5%) was obtained as an orange solid. 
Rho-SUMO-2G-PA
The product (45 mg, 10%) was obtained as an orange solid. LC-MS: R t 4.28 min; MS ESI MS+ (amu) calcd: 10857; found 10857 (deconv.).
Rho-SUMO-3G-PA
The product (44 mg, 10%) was obtained as an orange solid. LC-MS: R t 4.28 min; MS ESI MS+ (amu) calcd: 10773; found 10773 (deconv.).
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Preparation K11 diSUMO-2-VA probe
SUMO-2 K11Dab mutant
The SUMO-2 peptide sequence with K11 to Dab(Alloc) mutation was synthesized on 
SUMO-2G-SEt
The SUMO-2G peptide sequence was synthesized on a trityl resin following the general procedure and using Boc protected norleucine as final amino acid (40 μmol).
The methionine and cysteine residues in the sequence were replaced by the known 
Thiol elimination of the warhead -K11 diSUMO-2-VA
To a solution of the K11-linked precursor in 50 mM sodium phosphate buffer (pH 8, 0.5 mg/mL) 2,5-dibromohexandiamide (100 eq.) was added. The reaction mixture was incubated at 37ºC overnight and spun down to remove the insoluble dibromide. Correct folding of the purified synthetic diSUMO-2-VA was verified by CD spectroscopy (see general procedure page S10 and Figure S5 ).
Mono control probe: K11 SUMO-2 ABP
The SUMO-2 peptide sequence with K11 to Dab(Alloc) mutation was synthesized on and shaken overnight at room temperature with 4-(((allyloxy)carbonyl)amino)but-2-S17 enoic acid (4 eq), PyBOP (4 eq) and DiPEA (8 eq). 
Visualization of Rho-SUMO conjugates
Labeled enyzmes were visualized by in-gel fluorescence using either the ProXPRESS 2D Proteomic imaging system (Perkin-Elmer) with a resolution of 100 μm and exposure time of 20 s, or using the Typhoon FLA imaging system (GE Healthcare Life Sciences) (λ ex /λ em ) 480/530 nm). Subsequently, gels were stained with Coomassie (Coomassie Brilliant Blue) and proteins were visualized using a Chemidoc XRS+System with Image Lab software (Bio-Rad).
SENP1 and SENP6 labeling
The activity of the synthesized Rho-SUMO-PA probes was verified using purified catalytic domains of the SENPs. To label the proteases, GST-SENP1 or GST-SENP6
(1.2 μg total protein) was incubated with Rho-SUMO-1, -2, -3-PA or Rho-Ub-PA (0.64 μg total probe each) in Tris buffer (50 mM Tris, 150 mM NaCl, pH 7.4) for 30 minutes at RT. The reaction was terminated by the addition of 3x SDS-PAGE Loading Buffer (Invitrogen) containing beta-mercaptoethanol. Samples were resolved by SDS-PAGE (4-12% NuPage gel) and visualized by in-gel fluorescence scanning followed by staining with Coomassie Brilliant Blue.
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SENP labeling with K11 diSUMO-2-VA
SENPs were expressed and purified according to the procedure reported in literature. [2] The catalytic domains of SENP1, 2, 3, 5, 6, 7 and 8 were expressed with a N-terminal His-tag and purified using TALON beads. After purification, SENP1, 2 and 8 were obtained in high yields while SENP 5, 6 and 7 were less yielding. SENP3
was expressed as insoluble protein and was difficult to solubilize in any buffer. Hence this sample was omitted in the results.
All SENPs (SENP1, 2, 5, 6, 7 and 8) were diluted in a buffer containing 50 mM TRIS.HCl (pH 7.6), 100 mM NaCl and 2 mM DTT up to a concentration of 1 mg/ml.
To 20 L of this enzyme stock solution was added 10 L of K11 diSUMO-2-VA probe from a stock solution of 2 mg/ml. The reaction was incubated at 37˚C for 1 hour with constant shaking. The reaction was terminated by the addition of 3x SDS-PAGE Loading Buffer (Invitrogen) containing beta-mercaptoethanol. Samples were resolved by SDS-PAGE (4-12% Invitrogen NuPage gel) and visualized by staining with Coomassie Brilliant Blue. by the addition of sample loading buffer containing beta-mercaptoethanol, followed by boiling for 10 min. Samples were resolved using standard SDS-PAGE, and probe reactivity was assessed by in-gel fluorescence scanning, followed by transfer onto nitrocellulose membranes and immunoblotting using mouse anti-Flag (1:1000 dilution; Sigma Aldrich, F3165), rabbit anti-SENP2 (1:1000 dilution; Bethyl, A303-016A) or mouse anti-β-actin (1:10000 dilution; Sigma Aldrich, A544), as indicated.
Labeling of endogenous enzymes in cell lysates
S20
Labeling of overexpressed SENPs in cell lysates
Fluorescent secondary antibodies anti-mouse-800 (1: 10000 dilution; LiCOR, 926-3210) and anti-rabbit-800 (1: 10000 dilution; LiCOR, 926-3211) were used for visualization of labeled proteins on LICOR Odyssey system v3.0.
Time-dependent labeling of SUMO-specific proteases
To investigate the reactivity of SUMO-specific proteases in a time-dependent manner, 4 µg of Rho-SUMO-1-PA, Rho-SUMO-2-PA, or diSUMO-2-VA were added to 250 µg Hela cell lysate, prepared as previously described. After incubation for the 
Quantification of probe electroporated into living cells
To quantify the amount of Rho-SUMO-PA actually entering the cells after electroporation, a standard curve with Rho-SUMO-1-PA or Rho-SUMO-2-PA ranging from 0.25-0.4 mg was generated. After in-gel fluorescence scanning, the fluorescence signal from the samples of cells electroporated with the SUMO-probes and the calibration curves was quantified using ImageQuant TL 8.1 Software (GE Healthcare Life Sciences). Calculation of the percentage of probe entering the cells indicates that about 82% of Rho-SUMO-1-PA and 93% of Rho-SUMO-2-PA are incorporated ( Figure S8 ).
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Confocal microscopy
For microscopy experiments, samples were fixed using 4% paraformaldehyde (Merck) in PBS and mounted on glass cover slips (Thermo Scientific) using Prolong
Gold mounting medium containing DAPI (Invitrogen). Image acquisition was performed collecting z stacks of 5 images per cell on a Leica SP5 or SP8 confocal microscope equipped with HyD detectors, oil immersion lens, a digital zoom of 2.5-4x. Image processing was performed using Image J software and the resulting images are represented as maximum z projections.
Figure S11. Analysis of crude SUMO proteins directly after SPPS. Diode array chromatogram (left) and MS spectrum (right). A) SUMO-1G; B) SUMO-2G; C)
SUMO-3G. 
Figure S24. LC-MS analysis of K11 diSUMO-2 precursor. Diode Array chromatogram (top). MS spectrum of peak (middle). Deconvulated mass of product peak (bottom).
Figure S25. LC-MS analysis of K11 diSUMO-2-VA. Diode Array chromatogram (top).
MS spectrum of peak (middle). Deconvulated mass of product peak (bottom).
